
Sinopharm Lanzhou Vaccine Production Base Project

Customer
Sinopharm
Location
Lanzhou,China
Overview
The polysaccharide-conjugate protein vaccine project of Lanzhou Institute of Biological Products (Sinopharm) covers an area of approximately 14,909 square meters and has a total construction area of approximately 63,343 square meters. The production workshop after completion achieves an annual output of 10 million doses of quadrivalent meningococcal conjugate vaccine, 25 million doses of 13-valent pneumococcal conjugate vaccine, and 30 million doses of typhoid polysaccharide-protein conjugate vaccine.
Our Solution
HUBER & RANNER supplied combined supply/exhaust AHU units to many biological product research institutes under China Biologic, totalling more than 600 units. Their stable and reliable operation has been recognized by customers.
Design Points
Run-around coil-type energy recovery system (KVS EDS); |
Built-in high-voltage electrical supply cabinet; |
Low-temperature cold storage units with enhanced thermal insulation. |